Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.410
+0.020 (0.59%)
At close: May 6, 2026, 4:00 PM EDT
3.411
+0.001 (0.03%)
After-hours: May 6, 2026, 7:55 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $604.06 million as of May 6, 2026. Its market cap has increased by 240.41% in one year.
Market Cap
604.06M
Enterprise Value
542.81M
1-Year Change
240.41%
Ranking
Category
Stock Price
$3.41
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $604.06M, a decrease of -62.88%. That is a compound annual growth rate of -24.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 600.52M | -2.25% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adlai Nortye | 620.00M |
| Aclaris Therapeutics | 615.92M |
| CorMedix | 610.95M |
| Ocugen | 609.33M |
| Crescent Biopharma | 600.45M |
| Zevra Therapeutics | 595.29M |
| Sutro Biopharma | 589.65M |
| ProKidney | 582.78M |